A prospective phase I and consecutive phase II, two-arm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarbazine (DTIC) in patients with advanced melanoma (MEL001)

Heudobler, D. and Haferkamp, S. and Seidl, A.-P. and Hart, C. and Loquai, C. and Weishaupt, C. and Sell, S. and Schultz, E. and Lueke, F. and Mayer, S. and Vogelhuber, M. and Herr, W. and Reichle, A. (2023) A prospective phase I and consecutive phase II, two-arm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarbazine (DTIC) in patients with advanced melanoma (MEL001). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	01 Mar 2024 08:47
Last Modified:	01 Mar 2024 08:47
URI:	https://pred.uni-regensburg.de/id/eprint/59559

Actions (login required)

View Item